BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24066104)

  • 1. Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
    Domínguez D JF; Egan GF; Gray MA; Poudel GR; Churchyard A; Chua P; Stout JC; Georgiou-Karistianis N
    PLoS One; 2013; 8(9):e74131. PubMed ID: 24066104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.
    Georgiou-Karistianis N; Gray MA; Domínguez D JF; Dymowski AR; Bohanna I; Johnston LA; Churchyard A; Chua P; Stout JC; Egan GF
    Neurobiol Dis; 2013 Mar; 51():82-92. PubMed ID: 23069680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
    Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
    Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
    Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study.
    Hobbs NZ; Cole JH; Farmer RE; Rees EM; Crawford HE; Malone IB; Roos RA; Sprengelmeyer R; Durr A; Landwehrmeyer B; Scahill RI; Tabrizi SJ; Frost C
    Neuroimage Clin; 2012; 2():204-11. PubMed ID: 24179770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
    Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
    Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
    Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease.
    Sritharan A; Egan GF; Johnston L; Horne M; Bradshaw JL; Bohanna I; Asadi H; Cunnington R; Churchyard AJ; Chua P; Farrow M; Georgiou-Karistianis N
    J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):257-62. PubMed ID: 19237387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive alterations in white matter microstructure across the timecourse of Huntington's disease.
    Estevez-Fraga C; Elmalem MS; Papoutsi M; Durr A; Rees EM; Hobbs NZ; Roos RAC; Landwehrmeyer B; Leavitt BR; Langbehn DR; Scahill RI; Rees G; Tabrizi SJ; Gregory S
    Brain Behav; 2023 Apr; 13(4):e2940. PubMed ID: 36917716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional changes during working memory in Huntington's disease: 30-month longitudinal data from the IMAGE-HD study.
    Poudel GR; Stout JC; Domínguez DJ; Gray MA; Salmon L; Churchyard A; Chua P; Borowsky B; Egan GF; Georgiou-Karistianis N
    Brain Struct Funct; 2015 Jan; 220(1):501-12. PubMed ID: 24240602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
    Georgiou-Karistianis N; Poudel GR; Domínguez D JF; Langmaid R; Gray MA; Churchyard A; Chua P; Borowsky B; Egan GF; Stout JC
    Brain Cogn; 2013 Oct; 83(1):80-91. PubMed ID: 23938592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
    Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
    Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal diffusion changes in prodromal and early HD: Evidence of white-matter tract deterioration.
    Shaffer JJ; Ghayoor A; Long JD; Kim RE; Lourens S; O'Donnell LJ; Westin CF; Rathi Y; Magnotta V; Paulsen JS; Johnson HJ
    Hum Brain Mapp; 2017 Mar; 38(3):1460-1477. PubMed ID: 28045213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease.
    Vandenberghe W; Demaerel P; Dom R; Maes F
    J Neurol; 2009 Jan; 256(1):109-14. PubMed ID: 19267169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
    Tabrizi SJ; Langbehn DR; Leavitt BR; Roos RA; Durr A; Craufurd D; Kennard C; Hicks SL; Fox NC; Scahill RI; Borowsky B; Tobin AJ; Rosas HD; Johnson H; Reilmann R; Landwehrmeyer B; Stout JC;
    Lancet Neurol; 2009 Sep; 8(9):791-801. PubMed ID: 19646924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Diffusion Tensor Imaging Shows Progressive Changes in White Matter in Huntington's Disease.
    Gregory S; Cole JH; Farmer RE; Rees EM; Roos RA; Sprengelmeyer R; Durr A; Landwehrmeyer B; Zhang H; Scahill RI; Tabrizi SJ; Frost C; Hobbs NZ
    J Huntingtons Dis; 2015; 4(4):333-46. PubMed ID: 26756590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study.
    Georgiou-Karistianis N; Stout JC; Domínguez D JF; Carron SP; Ando A; Churchyard A; Chua P; Bohanna I; Dymowski AR; Poudel G; Egan GF
    Hum Brain Mapp; 2014 May; 35(5):1847-64. PubMed ID: 23913754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.